Insights into the cellular and molecular contributions of MeCP2 overexpression to disease pathophysiology.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 3410636)

Published in J Neurosci on July 11, 2012

Authors

M Morgan Taylor1, Shachee Doshi

Author Affiliations

1: Neuroscience Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. taym@mail.med.upenn.edu

Articles cited by this

MeCP2, a key contributor to neurological disease, activates and represses transcription. Science (2008) 10.11

REST and its corepressors mediate plasticity of neuronal gene chromatin throughout neurogenesis. Cell (2005) 8.65

Failure of neuronal homeostasis results in common neuropsychiatric phenotypes. Nature (2008) 2.98

Mouse models of MeCP2 disorders share gene expression changes in the cerebellum and hypothalamus. Hum Mol Genet (2009) 2.00

Repressor element-1 silencing transcription factor (REST)-dependent epigenetic remodeling is critical to ischemia-induced neuronal death. Proc Natl Acad Sci U S A (2012) 1.48

Global ischemia induces downregulation of Glur2 mRNA and increases AMPA receptor-mediated Ca2+ influx in hippocampal CA1 neurons of gerbil. J Neurosci (1997) 1.39

Role of amyloid-beta glycine 33 in oligomerization, toxicity, and neuronal plasticity. J Neurosci (2009) 1.34

Induction and expression of GluA1 (GluR-A)-independent LTP in the hippocampus. Eur J Neurosci (2009) 1.24

A mouse model for MeCP2 duplication syndrome: MeCP2 overexpression impairs learning and memory and synaptic transmission. J Neurosci (2012) 1.18

The Rett syndrome protein MeCP2 regulates synaptic scaling. J Neurosci (2012) 1.16

Progressive cerebellar degenerative changes in the severe mental retardation syndrome caused by duplication of MECP2 and adjacent loci on Xq28. Eur J Pediatr (2010) 1.06

Isoform-specific toxicity of Mecp2 in postmitotic neurons: suppression of neurotoxicity by FoxG1. J Neurosci (2012) 1.01